Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
Eli Lilly (NYSE: LLY) has underperformed broader equities. While that's not much of an issue in the grand scheme of things, ...
On an adjusted basis, the U.S. drugmaker expects to earn between $22.50 and $24.00 per share in 2025. Analysts were expecting ...
Two healthcare stocks that may or may not be boring, but that regardless look like strong growth stocks to invest in this ...
Fred Alger Management, an investment management company, released its “Alger Spectra Fund” fourth quarter 2024 investor ...
In a recent press release, Eli Lilly's management said that the U.S. incretin ... The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors ...
it's about as confident tone as you can expect from or as you'd want from a management team," said Kevin Gade, chief operating officer at Bahl & Gaynor, which owns Lilly's shares. Eli Lilly also ...
Obesity drug maker Novo Nordisk forecast slower growth this year after Wegovy sales more than doubled in the fourth quarter, ...